Where Science Becomes Communication
A selection of medical writing, scientific communication and patient education projects showing how complex evidence becomes clear, accurate, audience-focused content.
Explore our work across patient education materials, regulatory and clinical documents, medical infographics, scientific white papers, perspective articles, conference materials and peer-reviewed publications. Each project is grounded in the evidence and built for its intended audience.
Select a category below to explore our work ↓
Patient Education & Informed Consent Content →
Making complex clinical information easier for patients to understand and act on.
Regulatory & Clinical Documentation →
Sample content and craft insight for regulatory documents.
Medical Infographics & Visual Narratives →
Infographics, mechanism-of-action illustrations, trial data snapshots and market analyses that turn clinical evidence into clear, skimmable visuals for clinicians, investors and patients
In-depth, evidence-based analysis for clinical, regulatory, and investor audiences navigating a competitive landscape.
Scientific Perspectives & Blogs →
First-person takes on emerging science and innovations.
Peer-Reviewed Publications & Conference Abstracts →
Peer-reviewed manuscripts and conference abstracts.
Our writers publish in high-impact journals, including Cell Stem Cell, Nature Communications, JACS and Nucleic Acids Research.
Clinical Research
Association of preoperative serum adipokines, insulin, and sex steroid hormones with breast cancer risk in Indian women. Indian Journal of Cancer, 2024. Impact Factor: 1.3
Preclinical and translational research
Fetal-like reversion in the regenerating intestine is regulated by mesenchymal asporin. Cell Stem Cell, 2025. Impact Factor: 25.2
Leveraging morphological profiling for mechanistic elucidation of metal-based anticancer compounds. JACS Au. 2026. Impact Factor: 8.5
yylncT defines a class of divergently transcribed lncRNAs and safeguards T-mediated mesodermal commitment of human PSCs. Cell Stem Cell, 2019. Impact Factor: 25.2
Haploinsufficiency of miR-143 and miR-145 reveals targetable dependencies in resistant del(5q) myelodysplastic neoplasm. Leukemia, 2025. Impact Factor: 13.4
Detection of RNA–DNA binding sites in long noncoding RNAs. Nucleic Acids Research, 2019. Impact Factor: 16.8
Pan-cancer analysis of S-phase-enriched lncRNAs identifies oncogenic drivers and biomarkers. Nature Communications, 2018. Impact Factor: 17.2
Long non-coding RNAs: emerging functional players in the pathobiology and progression of myeloid leukemia. Frontiers in RNA Research, 2024. Impact Factor: 6.3
Sestrin2 facilitates mitophagy by promoting Parkin translocation through ULK1-mediated Beclin1 phosphorylation. 2018, Scientific Reports. Impact Factor: 5.5
Sestrin2 facilitates glutamine-dependent transcription of PGC-1α and survival of liver cancer cells under glucose limitation. FEBS, 2018, Impact Factor: 5.62
RBX1-mediated ubiquitination of SESN2 promotes cell death upon prolonged mitochondrial damage in SH-SY5Y neuroblastoma cells. Molecular and Cellular Biochemistry, 2018. Impact Factor: 4.7
Sestrins: Darkhorse in the regulation of mitochondrial health and metabolism. Mol Bio Rep., 2023, Impact Factor: 3.2
Translational and clinical research
Kumar A, et al. Clinical-stage anticancer agent BOLD-100 demonstrates protective effects against chemotherapy-induced peripheral neuropathy. AACR, Cancer Res, 2026
Kumar A, et al. Clinical-stage anticancer agent BOLD-100 demonstrates protective effects against oxaliplatin-induced peripheral neuropathy in an in-vivo rat model. AACR, Cancer Res, 2025
Preclinical and basic research
Kumar A, et al. A hypoxic microenvironment entrains cells to acquire epigenetic memory to derive ferroptosis resistance in Ewing sarcoma. BC Cancer Summit, 2023
Kumar A, et al. Two to tango - metabolic affair between stem cells and its Paneth cell niche in the intestine. Cold Spring Harbor Laboratory (CSHL) Meeting, 2021
Kumar A, et al. Pink-1-independent regulation of Beclin-1 and Parkin interaction mediated by SESN2: "Alan Evans Shot" in mitophagy. Keystone Symposia, 2015